ArticleFrontiers in oncology2019
B-ALL With t(5;14)(q31;q32);
Open access · goldAbstract readCase Reports
In one paragraph
Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.Orphanet journal of rare diseases · 2023Guideline
- Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.Frontiers in medicine · 2022Pooled it
- Cardiac Infiltration as the First Manifestation of Acute Lymphoblastic Leukemia: A Systematic Review.Frontiers in oncology · 2022Pooled it
- Advances in the diagnosis and classification of B-ALL: comparative insights from updated guidelines.Blood advances · 2026Article
- Hypereosinophilia of persistent/unknown cause: a bone marrow-based study integrating WHO-HAEM5 criteria and myeloid next-generation sequencing.American journal of clinical pathology · 2026Article
- Case report: Eosinophilia as a rare symptom and primary sign of acute lymphoblastic leukemia with translocation (5;14)(q31;q32).Frontiers in oncology · 2026Article
- Article
- IGH::IL3-Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant.Genes, chromosomes & cancer · 2025Article
- Masked by eosinophils: a cryptic presentation of pediatric B-ALL with IGH rearrangement.Journal of hematopathology · 2025Article
- Genetics of B-Cell Acute Lymphoblastic Leukemia (B-ALL): Recent Updates and Indian Perspective.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025Review
- Deciphering IGH rearrangement complexity and detection strategies in acute lymphoblastic leukaemia.NPJ precision oncology · 2025Review
- Rethinking paraneoplastic eosinophilia.Haematologica · 2024Article
- Real-World Clinical Utility of Targeted RNA Sequencing in Leukemia Diagnosis and Management.Cancers · 2024Article
- Genetic alterations in lymphoblastic leukaemiaMedizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024Article
- Hematological Neoplasms with Eosinophilia.Cancers · 2024Review
- The multidisciplinary approach to eosinophilia.Frontiers in oncology · 2023Review
- Recurrent NovelFrontiers in oncology · 2022Article
- A NovelFrontiers in oncology · 2022Article
- Review
- LILRB4, from the immune system to the disease target.American journal of translational research · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 14 institutions in 3 countries.
Benjamin FournierDepartment of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Estelle BalducciHematology Laboratory, University Hospital Paul-Brousse, Assistance Publique des Hôpitaux de Paris (APHP), Villejuif, France.
Nicolas DuployezDepartment of Hematology, University Hospital, Lille, France.
Emmanuelle ClappierHematology Laboratory, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Wendy CuccuiniHematology Laboratory, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Chloé ArfeuilleDepartment of Genetics, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Aurélie Caye-EudeDepartment of Genetics, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Eric DelabesseDepartment of Haematology, Institut Universitaire de Cancérologie de Toulouse, CHU de Toulouse, Toulouse, France.
Elodie Bottollier-Lemallaz ColombDepartment of Pediatric Oncology and Hematology, University Hospital of Dijon, Dijon, France.
Karin NebralChildren's Cancer Research Institute (CCRI), St. Anna Kinderkrebsforschung, Vienna, Austria.
Marie-Lorraine ChrétienDepartment of Hematology, University Hospital of Dijon, Dijon, France.
Coralie DerrieuxHematology Laboratory, Hospital Saint Faron, Meaux, France.
Aurélie Cabannes-HamyTeenagers and Young Adults Hematology Unit, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Florent DumezyDepartment of Hematology, University Hospital, Lille, France.
Pascaline EtancelinDepartment of Oncology Genetics, Henri Becquerel Center, Rouen, France.
Odile FenneteauHematology Laboratory, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Jamile FrayferDepartment of Hematology, Hospital Saint Faron, Meaux, France.
Antoine GourmelDepartment of Pediatric Oncology, Hematology, Immunology, University Hospital of Amiens, Amiens, France.
Marie LoosveldHematology Laboratory, Timone Hospital, Assistance Publique-Hôpitaux de Marseille (APHM), CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), Aix Marseille University, Marseille, France.
Gérard MichelDepartment of Pediatric Hematology, Aix Marseille University, Marseille, France.
Nathalie NadalLaboratory of Cytogenetics, University Hospital of Dijon, Dijon, France.
Dominique PentherDepartment of Oncology Genetics, Henri Becquerel Center, Rouen, France.
Isabelle TigaudDepartment of Cytogenetics, Lyon-Sud Hospital, Lyon, France.
Elise FournierDepartment of Hematology, University Hospital, Lille, France.
Bettina ReismüllerDepartment of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Andishe AttarbaschiDepartment of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Marina Lafage-PochitaloffHematological Cytogenetics Laboratory, Timone Hospital-Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Groupe Francophone de Cytogénétique Hématologique (GFCH), Marseille, France.
André BaruchelDepartment of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Assistance Publique – Hôpitaux de Paris · FRSaint Louis University Hospital · USCHU Dijon Bourgogne · FRSt Anna Children's Hospital · ATAix-Marseille Université · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRHôpital Lyon Sud · FRHôpital Necker-Enfants Malades · FRHôpital Saint-Louis · FRLille’s Cardiology Hospital · FRUniversité de Lille · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
acute lymphoblastic leukemiaclinical and molecular epidemiologycytogenetics and molecular geneticseosinophiliaIKZF1 rearrangement
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.